LIVER INT 润色咨询

LIVER INTERNATIONAL

出版年份：2003 年文章数：2252 投稿命中率： 开通期刊会员，数据随心看

出版周期：Monthly 自引率：4.3% 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=1229352, encodeId=dbaf12293524b, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享：目前影响因子8.76分了，非常不错，希望明年到十分, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0c32045478, createdName=Dr.？？？, createdTime=Wed Jun 29 08:31:26 CST 2022, time=2022-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1221459, encodeId=1b251221459eb, content=mark, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200806/084a1fc92a044bc49a2f018db2b60b9d/e9eb8f6f5c374213895e9be5cfdc9022.jpg, createdBy=48191511589, createdName=peach_adore, createdTime=Sat May 21 21:26:45 CST 2022, time=2022-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192137, encodeId=70f4119213e9f, content=，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=02442867842, createdName=zhiyinghe2012, createdTime=Fri Feb 11 01:08:21 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953674, encodeId=e0e89536e488, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：投稿3天直接拒稿，效率高，投稿系统友好，但不容易中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=577f5476606, createdName=ms5000000232033363, createdTime=Sat Apr 03 22:25:24 CST 2021, time=2021-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=944420, encodeId=e23a94442026, content=投稿命中率:25.0<br>经验分享：头天下午投稿马上显示under review，第二天早上醒来直接被reject, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45bf2312999, createdName=缅怀21世纪, createdTime=Mon Mar 01 13:01:42 CST 2021, time=2021-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590466, encodeId=70dc59046653, content=审稿速度:1.0 | 投稿命中率:5.0<br>经验分享：三百多例样本量的临床研究被认为小样本，秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=51c02222748, createdName=12107b02m29(暂无昵称), createdTime=Fri May 08 00:00:00 CST 2020, time=2020-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587147, encodeId=76de58e147a7, content=近一年一审要多久，这次会不会因疫情耽搁？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib0MTGXCbVubxiaZIicmkGvQBPicpFB3LlYQtvCkn8fj6iaczhe3URcAqZjTsVXqZq6O36LxUyXHIOiaSp5BU8sjInDQF/0, createdBy=33671972820, createdName=wxsessionb9467e4a, createdTime=Sun Mar 22 06:03:00 CST 2020, time=2020-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582349, encodeId=143258234917, content=请问各位大侠，这个杂志需要提供患者签字的知情同意书嘛？如果是回顾性研究么，完全无创, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/7MZxBj3Bp9LFylDIwTx9Aibm3icNfevAibDxyXmlnlU06rGblZAwOKic5bYiaFgB9RYgdJ0EicictypVDIoCpP1hbarHA/132, createdBy=174c1670703, createdName=阿丫丫, createdTime=Sun Dec 29 00:00:00 CST 2019, time=2019-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581843, encodeId=4f3458184397, content=非常感谢<span class="quote">dujiang 2019-12-19 发表::<br>8月19投，11月25接收</span><span class="quote">dujiang 2019-12-19 00:00:00 发表:<br>8月19投，11月25接收</span>, beContent=dujiang 2019-12-19 发表:: 8月19投，11月25接收, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/MMxbq4GKvwKXuygVVZGkPsQ8kiaZUib9NLKibED0LQSnxvMarBibIumiaIhsg8kH7ZHWvUPb8XhG5jqg20VBdCQePiag/132, createdBy=1ec21992614, createdName=Dr.liang1003, createdTime=Fri Dec 20 00:00:00 CST 2019, time=2019-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581833, encodeId=1c78581833a7, content=8月19投，11月25接收<span class="quote">Dr.liang1003 2019-12-19 00:00:00 发表:<br>不好意思，想问一下，您审稿花了多长时间，10.31投稿一篇，现在还是审稿状态……</span>, beContent=Dr.liang1003 2019-12-19 00:00:00 发表: 不好意思，想问一下，您审稿花了多长时间，10.31投稿一篇，现在还是审稿状态……, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLaYGcq2jR8ySEWalFlEicicYzD5he3CJZ4qCCKibxsk54QPWpWyolIvG4cUgKOacP1B28qsAiarh5wOA/132, createdBy=277d2215936, createdName=dujiang, createdTime=Thu Dec 19 00:00:00 CST 2019, time=2019-12-19, status=1, ipAttribution=)]
    2022-06-29 Dr.？？？

    审稿速度:6.0 | 投稿命中率:25.0
    经验分享：目前影响因子8.76分了，非常不错，希望明年到十分

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1229352, encodeId=dbaf12293524b, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享：目前影响因子8.76分了，非常不错，希望明年到十分, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0c32045478, createdName=Dr.？？？, createdTime=Wed Jun 29 08:31:26 CST 2022, time=2022-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1221459, encodeId=1b251221459eb, content=mark, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200806/084a1fc92a044bc49a2f018db2b60b9d/e9eb8f6f5c374213895e9be5cfdc9022.jpg, createdBy=48191511589, createdName=peach_adore, createdTime=Sat May 21 21:26:45 CST 2022, time=2022-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192137, encodeId=70f4119213e9f, content=，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=02442867842, createdName=zhiyinghe2012, createdTime=Fri Feb 11 01:08:21 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953674, encodeId=e0e89536e488, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：投稿3天直接拒稿，效率高，投稿系统友好，但不容易中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=577f5476606, createdName=ms5000000232033363, createdTime=Sat Apr 03 22:25:24 CST 2021, time=2021-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=944420, encodeId=e23a94442026, content=投稿命中率:25.0<br>经验分享：头天下午投稿马上显示under review，第二天早上醒来直接被reject, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45bf2312999, createdName=缅怀21世纪, createdTime=Mon Mar 01 13:01:42 CST 2021, time=2021-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590466, encodeId=70dc59046653, content=审稿速度:1.0 | 投稿命中率:5.0<br>经验分享：三百多例样本量的临床研究被认为小样本，秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=51c02222748, createdName=12107b02m29(暂无昵称), createdTime=Fri May 08 00:00:00 CST 2020, time=2020-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587147, encodeId=76de58e147a7, content=近一年一审要多久，这次会不会因疫情耽搁？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib0MTGXCbVubxiaZIicmkGvQBPicpFB3LlYQtvCkn8fj6iaczhe3URcAqZjTsVXqZq6O36LxUyXHIOiaSp5BU8sjInDQF/0, createdBy=33671972820, createdName=wxsessionb9467e4a, createdTime=Sun Mar 22 06:03:00 CST 2020, time=2020-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582349, encodeId=143258234917, content=请问各位大侠，这个杂志需要提供患者签字的知情同意书嘛？如果是回顾性研究么，完全无创, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/7MZxBj3Bp9LFylDIwTx9Aibm3icNfevAibDxyXmlnlU06rGblZAwOKic5bYiaFgB9RYgdJ0EicictypVDIoCpP1hbarHA/132, createdBy=174c1670703, createdName=阿丫丫, createdTime=Sun Dec 29 00:00:00 CST 2019, time=2019-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581843, encodeId=4f3458184397, content=非常感谢<span class="quote">dujiang 2019-12-19 发表::<br>8月19投，11月25接收</span><span class="quote">dujiang 2019-12-19 00:00:00 发表:<br>8月19投，11月25接收</span>, beContent=dujiang 2019-12-19 发表:: 8月19投，11月25接收, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/MMxbq4GKvwKXuygVVZGkPsQ8kiaZUib9NLKibED0LQSnxvMarBibIumiaIhsg8kH7ZHWvUPb8XhG5jqg20VBdCQePiag/132, createdBy=1ec21992614, createdName=Dr.liang1003, createdTime=Fri Dec 20 00:00:00 CST 2019, time=2019-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581833, encodeId=1c78581833a7, content=8月19投，11月25接收<span class="quote">Dr.liang1003 2019-12-19 00:00:00 发表:<br>不好意思，想问一下，您审稿花了多长时间，10.31投稿一篇，现在还是审稿状态……</span>, beContent=Dr.liang1003 2019-12-19 00:00:00 发表: 不好意思，想问一下，您审稿花了多长时间，10.31投稿一篇，现在还是审稿状态……, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLaYGcq2jR8ySEWalFlEicicYzD5he3CJZ4qCCKibxsk54QPWpWyolIvG4cUgKOacP1B28qsAiarh5wOA/132, createdBy=277d2215936, createdName=dujiang, createdTime=Thu Dec 19 00:00:00 CST 2019, time=2019-12-19, status=1, ipAttribution=)]
    2022-05-21 peach_adore

    mark

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1229352, encodeId=dbaf12293524b, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享：目前影响因子8.76分了，非常不错，希望明年到十分, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0c32045478, createdName=Dr.？？？, createdTime=Wed Jun 29 08:31:26 CST 2022, time=2022-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1221459, encodeId=1b251221459eb, content=mark, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200806/084a1fc92a044bc49a2f018db2b60b9d/e9eb8f6f5c374213895e9be5cfdc9022.jpg, createdBy=48191511589, createdName=peach_adore, createdTime=Sat May 21 21:26:45 CST 2022, time=2022-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192137, encodeId=70f4119213e9f, content=，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=02442867842, createdName=zhiyinghe2012, createdTime=Fri Feb 11 01:08:21 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953674, encodeId=e0e89536e488, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：投稿3天直接拒稿，效率高，投稿系统友好，但不容易中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=577f5476606, createdName=ms5000000232033363, createdTime=Sat Apr 03 22:25:24 CST 2021, time=2021-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=944420, encodeId=e23a94442026, content=投稿命中率:25.0<br>经验分享：头天下午投稿马上显示under review，第二天早上醒来直接被reject, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45bf2312999, createdName=缅怀21世纪, createdTime=Mon Mar 01 13:01:42 CST 2021, time=2021-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590466, encodeId=70dc59046653, content=审稿速度:1.0 | 投稿命中率:5.0<br>经验分享：三百多例样本量的临床研究被认为小样本，秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=51c02222748, createdName=12107b02m29(暂无昵称), createdTime=Fri May 08 00:00:00 CST 2020, time=2020-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587147, encodeId=76de58e147a7, content=近一年一审要多久，这次会不会因疫情耽搁？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib0MTGXCbVubxiaZIicmkGvQBPicpFB3LlYQtvCkn8fj6iaczhe3URcAqZjTsVXqZq6O36LxUyXHIOiaSp5BU8sjInDQF/0, createdBy=33671972820, createdName=wxsessionb9467e4a, createdTime=Sun Mar 22 06:03:00 CST 2020, time=2020-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582349, encodeId=143258234917, content=请问各位大侠，这个杂志需要提供患者签字的知情同意书嘛？如果是回顾性研究么，完全无创, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/7MZxBj3Bp9LFylDIwTx9Aibm3icNfevAibDxyXmlnlU06rGblZAwOKic5bYiaFgB9RYgdJ0EicictypVDIoCpP1hbarHA/132, createdBy=174c1670703, createdName=阿丫丫, createdTime=Sun Dec 29 00:00:00 CST 2019, time=2019-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581843, encodeId=4f3458184397, content=非常感谢<span class="quote">dujiang 2019-12-19 发表::<br>8月19投，11月25接收</span><span class="quote">dujiang 2019-12-19 00:00:00 发表:<br>8月19投，11月25接收</span>, beContent=dujiang 2019-12-19 发表:: 8月19投，11月25接收, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/MMxbq4GKvwKXuygVVZGkPsQ8kiaZUib9NLKibED0LQSnxvMarBibIumiaIhsg8kH7ZHWvUPb8XhG5jqg20VBdCQePiag/132, createdBy=1ec21992614, createdName=Dr.liang1003, createdTime=Fri Dec 20 00:00:00 CST 2019, time=2019-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581833, encodeId=1c78581833a7, content=8月19投，11月25接收<span class="quote">Dr.liang1003 2019-12-19 00:00:00 发表:<br>不好意思，想问一下，您审稿花了多长时间，10.31投稿一篇，现在还是审稿状态……</span>, beContent=Dr.liang1003 2019-12-19 00:00:00 发表: 不好意思，想问一下，您审稿花了多长时间，10.31投稿一篇，现在还是审稿状态……, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLaYGcq2jR8ySEWalFlEicicYzD5he3CJZ4qCCKibxsk54QPWpWyolIvG4cUgKOacP1B28qsAiarh5wOA/132, createdBy=277d2215936, createdName=dujiang, createdTime=Thu Dec 19 00:00:00 CST 2019, time=2019-12-19, status=1, ipAttribution=)]
    2022-02-11 zhiyinghe2012

    ，

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1229352, encodeId=dbaf12293524b, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享：目前影响因子8.76分了，非常不错，希望明年到十分, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0c32045478, createdName=Dr.？？？, createdTime=Wed Jun 29 08:31:26 CST 2022, time=2022-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1221459, encodeId=1b251221459eb, content=mark, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200806/084a1fc92a044bc49a2f018db2b60b9d/e9eb8f6f5c374213895e9be5cfdc9022.jpg, createdBy=48191511589, createdName=peach_adore, createdTime=Sat May 21 21:26:45 CST 2022, time=2022-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192137, encodeId=70f4119213e9f, content=，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=02442867842, createdName=zhiyinghe2012, createdTime=Fri Feb 11 01:08:21 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953674, encodeId=e0e89536e488, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：投稿3天直接拒稿，效率高，投稿系统友好，但不容易中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=577f5476606, createdName=ms5000000232033363, createdTime=Sat Apr 03 22:25:24 CST 2021, time=2021-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=944420, encodeId=e23a94442026, content=投稿命中率:25.0<br>经验分享：头天下午投稿马上显示under review，第二天早上醒来直接被reject, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45bf2312999, createdName=缅怀21世纪, createdTime=Mon Mar 01 13:01:42 CST 2021, time=2021-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590466, encodeId=70dc59046653, content=审稿速度:1.0 | 投稿命中率:5.0<br>经验分享：三百多例样本量的临床研究被认为小样本，秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=51c02222748, createdName=12107b02m29(暂无昵称), createdTime=Fri May 08 00:00:00 CST 2020, time=2020-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587147, encodeId=76de58e147a7, content=近一年一审要多久，这次会不会因疫情耽搁？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib0MTGXCbVubxiaZIicmkGvQBPicpFB3LlYQtvCkn8fj6iaczhe3URcAqZjTsVXqZq6O36LxUyXHIOiaSp5BU8sjInDQF/0, createdBy=33671972820, createdName=wxsessionb9467e4a, createdTime=Sun Mar 22 06:03:00 CST 2020, time=2020-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582349, encodeId=143258234917, content=请问各位大侠，这个杂志需要提供患者签字的知情同意书嘛？如果是回顾性研究么，完全无创, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/7MZxBj3Bp9LFylDIwTx9Aibm3icNfevAibDxyXmlnlU06rGblZAwOKic5bYiaFgB9RYgdJ0EicictypVDIoCpP1hbarHA/132, createdBy=174c1670703, createdName=阿丫丫, createdTime=Sun Dec 29 00:00:00 CST 2019, time=2019-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581843, encodeId=4f3458184397, content=非常感谢<span class="quote">dujiang 2019-12-19 发表::<br>8月19投，11月25接收</span><span class="quote">dujiang 2019-12-19 00:00:00 发表:<br>8月19投，11月25接收</span>, beContent=dujiang 2019-12-19 发表:: 8月19投，11月25接收, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/MMxbq4GKvwKXuygVVZGkPsQ8kiaZUib9NLKibED0LQSnxvMarBibIumiaIhsg8kH7ZHWvUPb8XhG5jqg20VBdCQePiag/132, createdBy=1ec21992614, createdName=Dr.liang1003, createdTime=Fri Dec 20 00:00:00 CST 2019, time=2019-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581833, encodeId=1c78581833a7, content=8月19投，11月25接收<span class="quote">Dr.liang1003 2019-12-19 00:00:00 发表:<br>不好意思，想问一下，您审稿花了多长时间，10.31投稿一篇，现在还是审稿状态……</span>, beContent=Dr.liang1003 2019-12-19 00:00:00 发表: 不好意思，想问一下，您审稿花了多长时间，10.31投稿一篇，现在还是审稿状态……, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLaYGcq2jR8ySEWalFlEicicYzD5he3CJZ4qCCKibxsk54QPWpWyolIvG4cUgKOacP1B28qsAiarh5wOA/132, createdBy=277d2215936, createdName=dujiang, createdTime=Thu Dec 19 00:00:00 CST 2019, time=2019-12-19, status=1, ipAttribution=)]
    2021-04-03 ms5000000232033363

    审稿速度:1.0 | 投稿命中率:25.0
    经验分享：投稿3天直接拒稿，效率高，投稿系统友好，但不容易中

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1229352, encodeId=dbaf12293524b, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享：目前影响因子8.76分了，非常不错，希望明年到十分, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0c32045478, createdName=Dr.？？？, createdTime=Wed Jun 29 08:31:26 CST 2022, time=2022-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1221459, encodeId=1b251221459eb, content=mark, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200806/084a1fc92a044bc49a2f018db2b60b9d/e9eb8f6f5c374213895e9be5cfdc9022.jpg, createdBy=48191511589, createdName=peach_adore, createdTime=Sat May 21 21:26:45 CST 2022, time=2022-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192137, encodeId=70f4119213e9f, content=，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=02442867842, createdName=zhiyinghe2012, createdTime=Fri Feb 11 01:08:21 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953674, encodeId=e0e89536e488, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：投稿3天直接拒稿，效率高，投稿系统友好，但不容易中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=577f5476606, createdName=ms5000000232033363, createdTime=Sat Apr 03 22:25:24 CST 2021, time=2021-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=944420, encodeId=e23a94442026, content=投稿命中率:25.0<br>经验分享：头天下午投稿马上显示under review，第二天早上醒来直接被reject, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45bf2312999, createdName=缅怀21世纪, createdTime=Mon Mar 01 13:01:42 CST 2021, time=2021-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590466, encodeId=70dc59046653, content=审稿速度:1.0 | 投稿命中率:5.0<br>经验分享：三百多例样本量的临床研究被认为小样本，秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=51c02222748, createdName=12107b02m29(暂无昵称), createdTime=Fri May 08 00:00:00 CST 2020, time=2020-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587147, encodeId=76de58e147a7, content=近一年一审要多久，这次会不会因疫情耽搁？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib0MTGXCbVubxiaZIicmkGvQBPicpFB3LlYQtvCkn8fj6iaczhe3URcAqZjTsVXqZq6O36LxUyXHIOiaSp5BU8sjInDQF/0, createdBy=33671972820, createdName=wxsessionb9467e4a, createdTime=Sun Mar 22 06:03:00 CST 2020, time=2020-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582349, encodeId=143258234917, content=请问各位大侠，这个杂志需要提供患者签字的知情同意书嘛？如果是回顾性研究么，完全无创, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/7MZxBj3Bp9LFylDIwTx9Aibm3icNfevAibDxyXmlnlU06rGblZAwOKic5bYiaFgB9RYgdJ0EicictypVDIoCpP1hbarHA/132, createdBy=174c1670703, createdName=阿丫丫, createdTime=Sun Dec 29 00:00:00 CST 2019, time=2019-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581843, encodeId=4f3458184397, content=非常感谢<span class="quote">dujiang 2019-12-19 发表::<br>8月19投，11月25接收</span><span class="quote">dujiang 2019-12-19 00:00:00 发表:<br>8月19投，11月25接收</span>, beContent=dujiang 2019-12-19 发表:: 8月19投，11月25接收, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/MMxbq4GKvwKXuygVVZGkPsQ8kiaZUib9NLKibED0LQSnxvMarBibIumiaIhsg8kH7ZHWvUPb8XhG5jqg20VBdCQePiag/132, createdBy=1ec21992614, createdName=Dr.liang1003, createdTime=Fri Dec 20 00:00:00 CST 2019, time=2019-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581833, encodeId=1c78581833a7, content=8月19投，11月25接收<span class="quote">Dr.liang1003 2019-12-19 00:00:00 发表:<br>不好意思，想问一下，您审稿花了多长时间，10.31投稿一篇，现在还是审稿状态……</span>, beContent=Dr.liang1003 2019-12-19 00:00:00 发表: 不好意思，想问一下，您审稿花了多长时间，10.31投稿一篇，现在还是审稿状态……, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLaYGcq2jR8ySEWalFlEicicYzD5he3CJZ4qCCKibxsk54QPWpWyolIvG4cUgKOacP1B28qsAiarh5wOA/132, createdBy=277d2215936, createdName=dujiang, createdTime=Thu Dec 19 00:00:00 CST 2019, time=2019-12-19, status=1, ipAttribution=)]
    2021-03-01 缅怀21世纪

    投稿命中率:25.0
    经验分享：头天下午投稿马上显示under review，第二天早上醒来直接被reject

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1229352, encodeId=dbaf12293524b, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享：目前影响因子8.76分了，非常不错，希望明年到十分, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0c32045478, createdName=Dr.？？？, createdTime=Wed Jun 29 08:31:26 CST 2022, time=2022-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1221459, encodeId=1b251221459eb, content=mark, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200806/084a1fc92a044bc49a2f018db2b60b9d/e9eb8f6f5c374213895e9be5cfdc9022.jpg, createdBy=48191511589, createdName=peach_adore, createdTime=Sat May 21 21:26:45 CST 2022, time=2022-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192137, encodeId=70f4119213e9f, content=，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=02442867842, createdName=zhiyinghe2012, createdTime=Fri Feb 11 01:08:21 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953674, encodeId=e0e89536e488, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：投稿3天直接拒稿，效率高，投稿系统友好，但不容易中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=577f5476606, createdName=ms5000000232033363, createdTime=Sat Apr 03 22:25:24 CST 2021, time=2021-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=944420, encodeId=e23a94442026, content=投稿命中率:25.0<br>经验分享：头天下午投稿马上显示under review，第二天早上醒来直接被reject, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45bf2312999, createdName=缅怀21世纪, createdTime=Mon Mar 01 13:01:42 CST 2021, time=2021-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590466, encodeId=70dc59046653, content=审稿速度:1.0 | 投稿命中率:5.0<br>经验分享：三百多例样本量的临床研究被认为小样本，秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=51c02222748, createdName=12107b02m29(暂无昵称), createdTime=Fri May 08 00:00:00 CST 2020, time=2020-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587147, encodeId=76de58e147a7, content=近一年一审要多久，这次会不会因疫情耽搁？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib0MTGXCbVubxiaZIicmkGvQBPicpFB3LlYQtvCkn8fj6iaczhe3URcAqZjTsVXqZq6O36LxUyXHIOiaSp5BU8sjInDQF/0, createdBy=33671972820, createdName=wxsessionb9467e4a, createdTime=Sun Mar 22 06:03:00 CST 2020, time=2020-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582349, encodeId=143258234917, content=请问各位大侠，这个杂志需要提供患者签字的知情同意书嘛？如果是回顾性研究么，完全无创, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/7MZxBj3Bp9LFylDIwTx9Aibm3icNfevAibDxyXmlnlU06rGblZAwOKic5bYiaFgB9RYgdJ0EicictypVDIoCpP1hbarHA/132, createdBy=174c1670703, createdName=阿丫丫, createdTime=Sun Dec 29 00:00:00 CST 2019, time=2019-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581843, encodeId=4f3458184397, content=非常感谢<span class="quote">dujiang 2019-12-19 发表::<br>8月19投，11月25接收</span><span class="quote">dujiang 2019-12-19 00:00:00 发表:<br>8月19投，11月25接收</span>, beContent=dujiang 2019-12-19 发表:: 8月19投，11月25接收, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/MMxbq4GKvwKXuygVVZGkPsQ8kiaZUib9NLKibED0LQSnxvMarBibIumiaIhsg8kH7ZHWvUPb8XhG5jqg20VBdCQePiag/132, createdBy=1ec21992614, createdName=Dr.liang1003, createdTime=Fri Dec 20 00:00:00 CST 2019, time=2019-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581833, encodeId=1c78581833a7, content=8月19投，11月25接收<span class="quote">Dr.liang1003 2019-12-19 00:00:00 发表:<br>不好意思，想问一下，您审稿花了多长时间，10.31投稿一篇，现在还是审稿状态……</span>, beContent=Dr.liang1003 2019-12-19 00:00:00 发表: 不好意思，想问一下，您审稿花了多长时间，10.31投稿一篇，现在还是审稿状态……, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLaYGcq2jR8ySEWalFlEicicYzD5he3CJZ4qCCKibxsk54QPWpWyolIvG4cUgKOacP1B28qsAiarh5wOA/132, createdBy=277d2215936, createdName=dujiang, createdTime=Thu Dec 19 00:00:00 CST 2019, time=2019-12-19, status=1, ipAttribution=)]
    2020-05-08 12107b02m29(暂无昵称)

    审稿速度:1.0 | 投稿命中率:5.0
    经验分享：三百多例样本量的临床研究被认为小样本，秒拒

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1229352, encodeId=dbaf12293524b, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享：目前影响因子8.76分了，非常不错，希望明年到十分, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0c32045478, createdName=Dr.？？？, createdTime=Wed Jun 29 08:31:26 CST 2022, time=2022-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1221459, encodeId=1b251221459eb, content=mark, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200806/084a1fc92a044bc49a2f018db2b60b9d/e9eb8f6f5c374213895e9be5cfdc9022.jpg, createdBy=48191511589, createdName=peach_adore, createdTime=Sat May 21 21:26:45 CST 2022, time=2022-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192137, encodeId=70f4119213e9f, content=，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=02442867842, createdName=zhiyinghe2012, createdTime=Fri Feb 11 01:08:21 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953674, encodeId=e0e89536e488, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：投稿3天直接拒稿，效率高，投稿系统友好，但不容易中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=577f5476606, createdName=ms5000000232033363, createdTime=Sat Apr 03 22:25:24 CST 2021, time=2021-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=944420, encodeId=e23a94442026, content=投稿命中率:25.0<br>经验分享：头天下午投稿马上显示under review，第二天早上醒来直接被reject, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45bf2312999, createdName=缅怀21世纪, createdTime=Mon Mar 01 13:01:42 CST 2021, time=2021-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590466, encodeId=70dc59046653, content=审稿速度:1.0 | 投稿命中率:5.0<br>经验分享：三百多例样本量的临床研究被认为小样本，秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=51c02222748, createdName=12107b02m29(暂无昵称), createdTime=Fri May 08 00:00:00 CST 2020, time=2020-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587147, encodeId=76de58e147a7, content=近一年一审要多久，这次会不会因疫情耽搁？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib0MTGXCbVubxiaZIicmkGvQBPicpFB3LlYQtvCkn8fj6iaczhe3URcAqZjTsVXqZq6O36LxUyXHIOiaSp5BU8sjInDQF/0, createdBy=33671972820, createdName=wxsessionb9467e4a, createdTime=Sun Mar 22 06:03:00 CST 2020, time=2020-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582349, encodeId=143258234917, content=请问各位大侠，这个杂志需要提供患者签字的知情同意书嘛？如果是回顾性研究么，完全无创, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/7MZxBj3Bp9LFylDIwTx9Aibm3icNfevAibDxyXmlnlU06rGblZAwOKic5bYiaFgB9RYgdJ0EicictypVDIoCpP1hbarHA/132, createdBy=174c1670703, createdName=阿丫丫, createdTime=Sun Dec 29 00:00:00 CST 2019, time=2019-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581843, encodeId=4f3458184397, content=非常感谢<span class="quote">dujiang 2019-12-19 发表::<br>8月19投，11月25接收</span><span class="quote">dujiang 2019-12-19 00:00:00 发表:<br>8月19投，11月25接收</span>, beContent=dujiang 2019-12-19 发表:: 8月19投，11月25接收, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/MMxbq4GKvwKXuygVVZGkPsQ8kiaZUib9NLKibED0LQSnxvMarBibIumiaIhsg8kH7ZHWvUPb8XhG5jqg20VBdCQePiag/132, createdBy=1ec21992614, createdName=Dr.liang1003, createdTime=Fri Dec 20 00:00:00 CST 2019, time=2019-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581833, encodeId=1c78581833a7, content=8月19投，11月25接收<span class="quote">Dr.liang1003 2019-12-19 00:00:00 发表:<br>不好意思，想问一下，您审稿花了多长时间，10.31投稿一篇，现在还是审稿状态……</span>, beContent=Dr.liang1003 2019-12-19 00:00:00 发表: 不好意思，想问一下，您审稿花了多长时间，10.31投稿一篇，现在还是审稿状态……, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLaYGcq2jR8ySEWalFlEicicYzD5he3CJZ4qCCKibxsk54QPWpWyolIvG4cUgKOacP1B28qsAiarh5wOA/132, createdBy=277d2215936, createdName=dujiang, createdTime=Thu Dec 19 00:00:00 CST 2019, time=2019-12-19, status=1, ipAttribution=)]
    2020-03-22 wxsessionb9467e4a

    近一年一审要多久，这次会不会因疫情耽搁？

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=1229352, encodeId=dbaf12293524b, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享：目前影响因子8.76分了，非常不错，希望明年到十分, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0c32045478, createdName=Dr.？？？, createdTime=Wed Jun 29 08:31:26 CST 2022, time=2022-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1221459, encodeId=1b251221459eb, content=mark, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200806/084a1fc92a044bc49a2f018db2b60b9d/e9eb8f6f5c374213895e9be5cfdc9022.jpg, createdBy=48191511589, createdName=peach_adore, createdTime=Sat May 21 21:26:45 CST 2022, time=2022-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192137, encodeId=70f4119213e9f, content=，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=02442867842, createdName=zhiyinghe2012, createdTime=Fri Feb 11 01:08:21 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953674, encodeId=e0e89536e488, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：投稿3天直接拒稿，效率高，投稿系统友好，但不容易中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=577f5476606, createdName=ms5000000232033363, createdTime=Sat Apr 03 22:25:24 CST 2021, time=2021-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=944420, encodeId=e23a94442026, content=投稿命中率:25.0<br>经验分享：头天下午投稿马上显示under review，第二天早上醒来直接被reject, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45bf2312999, createdName=缅怀21世纪, createdTime=Mon Mar 01 13:01:42 CST 2021, time=2021-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590466, encodeId=70dc59046653, content=审稿速度:1.0 | 投稿命中率:5.0<br>经验分享：三百多例样本量的临床研究被认为小样本，秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=51c02222748, createdName=12107b02m29(暂无昵称), createdTime=Fri May 08 00:00:00 CST 2020, time=2020-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587147, encodeId=76de58e147a7, content=近一年一审要多久，这次会不会因疫情耽搁？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib0MTGXCbVubxiaZIicmkGvQBPicpFB3LlYQtvCkn8fj6iaczhe3URcAqZjTsVXqZq6O36LxUyXHIOiaSp5BU8sjInDQF/0, createdBy=33671972820, createdName=wxsessionb9467e4a, createdTime=Sun Mar 22 06:03:00 CST 2020, time=2020-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582349, encodeId=143258234917, content=请问各位大侠，这个杂志需要提供患者签字的知情同意书嘛？如果是回顾性研究么，完全无创, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/7MZxBj3Bp9LFylDIwTx9Aibm3icNfevAibDxyXmlnlU06rGblZAwOKic5bYiaFgB9RYgdJ0EicictypVDIoCpP1hbarHA/132, createdBy=174c1670703, createdName=阿丫丫, createdTime=Sun Dec 29 00:00:00 CST 2019, time=2019-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581843, encodeId=4f3458184397, content=非常感谢<span class="quote">dujiang 2019-12-19 发表::<br>8月19投，11月25接收</span><span class="quote">dujiang 2019-12-19 00:00:00 发表:<br>8月19投，11月25接收</span>, beContent=dujiang 2019-12-19 发表:: 8月19投，11月25接收, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/MMxbq4GKvwKXuygVVZGkPsQ8kiaZUib9NLKibED0LQSnxvMarBibIumiaIhsg8kH7ZHWvUPb8XhG5jqg20VBdCQePiag/132, createdBy=1ec21992614, createdName=Dr.liang1003, createdTime=Fri Dec 20 00:00:00 CST 2019, time=2019-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581833, encodeId=1c78581833a7, content=8月19投，11月25接收<span class="quote">Dr.liang1003 2019-12-19 00:00:00 发表:<br>不好意思，想问一下，您审稿花了多长时间，10.31投稿一篇，现在还是审稿状态……</span>, beContent=Dr.liang1003 2019-12-19 00:00:00 发表: 不好意思，想问一下，您审稿花了多长时间，10.31投稿一篇，现在还是审稿状态……, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLaYGcq2jR8ySEWalFlEicicYzD5he3CJZ4qCCKibxsk54QPWpWyolIvG4cUgKOacP1B28qsAiarh5wOA/132, createdBy=277d2215936, createdName=dujiang, createdTime=Thu Dec 19 00:00:00 CST 2019, time=2019-12-19, status=1, ipAttribution=)]
    2019-12-29 阿丫丫

    请问各位大侠，这个杂志需要提供患者签字的知情同意书嘛？如果是回顾性研究么，完全无创

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=1229352, encodeId=dbaf12293524b, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享：目前影响因子8.76分了，非常不错，希望明年到十分, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0c32045478, createdName=Dr.？？？, createdTime=Wed Jun 29 08:31:26 CST 2022, time=2022-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1221459, encodeId=1b251221459eb, content=mark, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200806/084a1fc92a044bc49a2f018db2b60b9d/e9eb8f6f5c374213895e9be5cfdc9022.jpg, createdBy=48191511589, createdName=peach_adore, createdTime=Sat May 21 21:26:45 CST 2022, time=2022-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192137, encodeId=70f4119213e9f, content=，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=02442867842, createdName=zhiyinghe2012, createdTime=Fri Feb 11 01:08:21 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953674, encodeId=e0e89536e488, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：投稿3天直接拒稿，效率高，投稿系统友好，但不容易中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=577f5476606, createdName=ms5000000232033363, createdTime=Sat Apr 03 22:25:24 CST 2021, time=2021-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=944420, encodeId=e23a94442026, content=投稿命中率:25.0<br>经验分享：头天下午投稿马上显示under review，第二天早上醒来直接被reject, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45bf2312999, createdName=缅怀21世纪, createdTime=Mon Mar 01 13:01:42 CST 2021, time=2021-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590466, encodeId=70dc59046653, content=审稿速度:1.0 | 投稿命中率:5.0<br>经验分享：三百多例样本量的临床研究被认为小样本，秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=51c02222748, createdName=12107b02m29(暂无昵称), createdTime=Fri May 08 00:00:00 CST 2020, time=2020-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587147, encodeId=76de58e147a7, content=近一年一审要多久，这次会不会因疫情耽搁？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib0MTGXCbVubxiaZIicmkGvQBPicpFB3LlYQtvCkn8fj6iaczhe3URcAqZjTsVXqZq6O36LxUyXHIOiaSp5BU8sjInDQF/0, createdBy=33671972820, createdName=wxsessionb9467e4a, createdTime=Sun Mar 22 06:03:00 CST 2020, time=2020-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582349, encodeId=143258234917, content=请问各位大侠，这个杂志需要提供患者签字的知情同意书嘛？如果是回顾性研究么，完全无创, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/7MZxBj3Bp9LFylDIwTx9Aibm3icNfevAibDxyXmlnlU06rGblZAwOKic5bYiaFgB9RYgdJ0EicictypVDIoCpP1hbarHA/132, createdBy=174c1670703, createdName=阿丫丫, createdTime=Sun Dec 29 00:00:00 CST 2019, time=2019-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581843, encodeId=4f3458184397, content=非常感谢<span class="quote">dujiang 2019-12-19 发表::<br>8月19投，11月25接收</span><span class="quote">dujiang 2019-12-19 00:00:00 发表:<br>8月19投，11月25接收</span>, beContent=dujiang 2019-12-19 发表:: 8月19投，11月25接收, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/MMxbq4GKvwKXuygVVZGkPsQ8kiaZUib9NLKibED0LQSnxvMarBibIumiaIhsg8kH7ZHWvUPb8XhG5jqg20VBdCQePiag/132, createdBy=1ec21992614, createdName=Dr.liang1003, createdTime=Fri Dec 20 00:00:00 CST 2019, time=2019-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581833, encodeId=1c78581833a7, content=8月19投，11月25接收<span class="quote">Dr.liang1003 2019-12-19 00:00:00 发表:<br>不好意思，想问一下，您审稿花了多长时间，10.31投稿一篇，现在还是审稿状态……</span>, beContent=Dr.liang1003 2019-12-19 00:00:00 发表: 不好意思，想问一下，您审稿花了多长时间，10.31投稿一篇，现在还是审稿状态……, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLaYGcq2jR8ySEWalFlEicicYzD5he3CJZ4qCCKibxsk54QPWpWyolIvG4cUgKOacP1B28qsAiarh5wOA/132, createdBy=277d2215936, createdName=dujiang, createdTime=Thu Dec 19 00:00:00 CST 2019, time=2019-12-19, status=1, ipAttribution=)]
    2019-12-20 Dr.liang1003

    非常感谢dujiang 2019-12-19 发表::
    8月19投，11月25接收    dujiang 2019-12-19 00:00:00 发表:
    8月19投，11月25接收

    dujiang 2019-12-19 发表:: 8月19投，11月25接收

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=1229352, encodeId=dbaf12293524b, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享：目前影响因子8.76分了，非常不错，希望明年到十分, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0c32045478, createdName=Dr.？？？, createdTime=Wed Jun 29 08:31:26 CST 2022, time=2022-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1221459, encodeId=1b251221459eb, content=mark, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200806/084a1fc92a044bc49a2f018db2b60b9d/e9eb8f6f5c374213895e9be5cfdc9022.jpg, createdBy=48191511589, createdName=peach_adore, createdTime=Sat May 21 21:26:45 CST 2022, time=2022-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192137, encodeId=70f4119213e9f, content=，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=02442867842, createdName=zhiyinghe2012, createdTime=Fri Feb 11 01:08:21 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953674, encodeId=e0e89536e488, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：投稿3天直接拒稿，效率高，投稿系统友好，但不容易中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=577f5476606, createdName=ms5000000232033363, createdTime=Sat Apr 03 22:25:24 CST 2021, time=2021-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=944420, encodeId=e23a94442026, content=投稿命中率:25.0<br>经验分享：头天下午投稿马上显示under review，第二天早上醒来直接被reject, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45bf2312999, createdName=缅怀21世纪, createdTime=Mon Mar 01 13:01:42 CST 2021, time=2021-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590466, encodeId=70dc59046653, content=审稿速度:1.0 | 投稿命中率:5.0<br>经验分享：三百多例样本量的临床研究被认为小样本，秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=51c02222748, createdName=12107b02m29(暂无昵称), createdTime=Fri May 08 00:00:00 CST 2020, time=2020-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587147, encodeId=76de58e147a7, content=近一年一审要多久，这次会不会因疫情耽搁？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib0MTGXCbVubxiaZIicmkGvQBPicpFB3LlYQtvCkn8fj6iaczhe3URcAqZjTsVXqZq6O36LxUyXHIOiaSp5BU8sjInDQF/0, createdBy=33671972820, createdName=wxsessionb9467e4a, createdTime=Sun Mar 22 06:03:00 CST 2020, time=2020-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582349, encodeId=143258234917, content=请问各位大侠，这个杂志需要提供患者签字的知情同意书嘛？如果是回顾性研究么，完全无创, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/7MZxBj3Bp9LFylDIwTx9Aibm3icNfevAibDxyXmlnlU06rGblZAwOKic5bYiaFgB9RYgdJ0EicictypVDIoCpP1hbarHA/132, createdBy=174c1670703, createdName=阿丫丫, createdTime=Sun Dec 29 00:00:00 CST 2019, time=2019-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581843, encodeId=4f3458184397, content=非常感谢<span class="quote">dujiang 2019-12-19 发表::<br>8月19投，11月25接收</span><span class="quote">dujiang 2019-12-19 00:00:00 发表:<br>8月19投，11月25接收</span>, beContent=dujiang 2019-12-19 发表:: 8月19投，11月25接收, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/MMxbq4GKvwKXuygVVZGkPsQ8kiaZUib9NLKibED0LQSnxvMarBibIumiaIhsg8kH7ZHWvUPb8XhG5jqg20VBdCQePiag/132, createdBy=1ec21992614, createdName=Dr.liang1003, createdTime=Fri Dec 20 00:00:00 CST 2019, time=2019-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581833, encodeId=1c78581833a7, content=8月19投，11月25接收<span class="quote">Dr.liang1003 2019-12-19 00:00:00 发表:<br>不好意思，想问一下，您审稿花了多长时间，10.31投稿一篇，现在还是审稿状态……</span>, beContent=Dr.liang1003 2019-12-19 00:00:00 发表: 不好意思，想问一下，您审稿花了多长时间，10.31投稿一篇，现在还是审稿状态……, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLaYGcq2jR8ySEWalFlEicicYzD5he3CJZ4qCCKibxsk54QPWpWyolIvG4cUgKOacP1B28qsAiarh5wOA/132, createdBy=277d2215936, createdName=dujiang, createdTime=Thu Dec 19 00:00:00 CST 2019, time=2019-12-19, status=1, ipAttribution=)]
    2019-12-19 dujiang

    8月19投，11月25接收Dr.liang1003 2019-12-19 00:00:00 发表:
    不好意思，想问一下，您审稿花了多长时间，10.31投稿一篇，现在还是审稿状态……

    Dr.liang1003 2019-12-19 00:00:00 发表: 不好意思，想问一下，您审稿花了多长时间，10.31投稿一篇，现在还是审稿状态……

    0

共112条页码: 3/12页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分